-
EP3962528
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3962528
| EP3962528 - THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD123 IMMUNOCONJUGATES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.02.2022 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 06.11.2020 | Most recent event Tooltip | 29.04.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states ImmunoGen, Inc. 830 Winter Street Waltham, MA 02451 / US | [2024/12] |
| Former [2022/10] | For all designated states Immunogen, Inc. 830 Winter Street Waltham, MA 02451 / US | Inventor(s) | 01 /
ADAMS, Sharlene 45 Rosemont Ave. Waltham, Massachusetts 02451 / US | 02 /
SLOSS, Callum M. 72 Greenwood Street Wakefield, Massachusetts 01880 / US | 03 /
ZWEIDLER-MCKAY, Patrick 111 Old Country Road Lincoln, Massachusetts 01773 / US | [2022/10] | Representative(s) | Simmons & Simmons LLP (Munich), et al Lehel Carré Thierschplatz 6 80538 Munich / DE | [N/P] |
| Former [2022/10] | Nottrott, Stephanie Patentanwälte Isenbruck Bösl Hörschler PartG mbB Seckenheimer Landstr. 4 68163 Mannheim / DE | Application number, filing date | 20798446.9 | 29.04.2020 | [2022/10] | WO2020US30478 | Priority number, date | US201962839974P | 29.04.2019 Original published format: US 201962839974 P | US201962860598P | 12.06.2019 Original published format: US 201962860598 P | [2022/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020223351 | Date: | 05.11.2020 | Language: | EN | [2020/45] | Type: | A1 Application with search report | No.: | EP3962528 | Date: | 09.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.11.2020 takes the place of the publication of the European patent application. | [2022/10] | Search report(s) | International search report - published on: | US | 05.11.2020 | (Supplementary) European search report - dispatched on: | EP | 08.12.2022 | Classification | IPC: | A61K39/395, C07K16/28, C07K16/30, A61P35/00, A61K31/635, A61K31/706, A61K38/00, A61K45/06, A61K47/68, A61P35/02 | [2023/02] | CPC: |
C07K16/2866 (EP,IL,KR,US);
A61K47/6849 (EP,IL,KR,US);
A61K31/551 (KR);
A61K31/635 (EP,IL,KR);
A61K31/706 (EP,IL,KR);
A61K38/00 (EP,IL);
A61K39/395 (EP,IL);
A61K45/06 (EP,IL,KR);
A61K47/6803 (IL,KR);
A61K47/68035 (EP,US);
A61P35/00 (IL,US);
A61P35/02 (EP,IL,KR);
| C-Set: |
A61K31/635, A61K2300/00 (EP);
A61K31/706, A61K2300/00 (EP);
A61K39/395, A61K2300/00 (EP)
|
| Former IPC [2022/10] | A61K39/395, C07K16/28, C07K16/30, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/10] | Extension states | BA | 29.11.2021 | ME | 29.11.2021 | Validation states | KH | 29.11.2021 | MA | 29.11.2021 | MD | 29.11.2021 | TN | 29.11.2021 | Title | German: | THERAPEUTISCHE KOMBINATIONEN MIT ANTI-CD123-IMMUNKONJUGATEN | [2022/10] | English: | THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD123 IMMUNOCONJUGATES | [2022/10] | French: | COMBINAISONS THÉRAPEUTIQUES COMPRENANT DES IMMUNOCONJUGUÉS ANTI-CD123 | [2022/10] | Entry into regional phase | 29.11.2021 | National basic fee paid | 29.11.2021 | Search fee paid | 29.11.2021 | Designation fee(s) paid | 29.11.2021 | Examination fee paid | Examination procedure | 29.11.2021 | Examination requested [2022/10] | 13.07.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 29.11.2021 | Renewal fee patent year 03 | 27.04.2023 | Renewal fee patent year 04 | 29.04.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2019012328 (BIOSIGHT PHARMA [IL]); | International search | [Y]US2019111147 (FLEMING MICHAEL [US], et al); |